Lactic acidosis
Dr. Nazia Qazi
INTRODUCTION
 Lactic acid is the normal endpoint of the anaerobic
breakdown of glucose in the tissues
 Normal plasma lactate: 0.5 to 1.5 meq/L
DEFINITION
 Lactic acidosis is a pathological state diagnosed when the
serum concentration of lactate or lactic acid is
persistently 5mmol/l or greater
 There is significant acidemia and serum pH< 7.35
FORMATION OF LACTIC ACID
 RBCs, brain and skin are major sources of lactic acid
 During exercise skeletal muscles release significant
amount of lactic acid
 Liver and kidneys utilize lactic acid for biosynthesis of
glucose
 It is catalyzed by the enzyme lactate dehydrogenase
 The body tissues produces 1500 mmoles of lactate each
day
 The lactate enters blood stream and metabolized meanly
by liver (60% in Cori Cycle) and kidneys (30%) to glucose
 All tissues can produce lactate under anaerobic conditions
 Skeletal muscles produce high amounts of lactate during
vigorous exercise
 Oxygen may not reach the muscle fast enough to keep up
with the workout
LACTATE METABOLISM IN TISSUE
PYRUVATE TO LACTATE
 The reduction of pyruvate by NADH+ catalyzed by to form lactate by lactate
dehydrogenase on anaerobic glycolysis to generate ATP
 The reaction takes place in the cells when the amount of oxygen is less, as in
muscle during intense activity
 Pyruvate lactate regenerates NAD+ which prevents glycolysis from cease to
function
 Lactate cannot be used to generate energy
 Lactate must be removed from the muscles to prevent lactic acidosis
Carried by the
Blood to the Liver
to be converted
into Glucose
CORI CYCLE
 It is named after Carl Cori and Gerty Cori in 1929
 It is also known as lactic acid cycle or glucose lactate or lactic acid
fermentation
 It involves the synthesis of glucose through gluconeogenesis from lactate
synthesized in the skeletal muscle
 It occurs when the muscles need energy or during hypoxia
-Intense exercise
-Sprinting
THE CORI CYCLE
Table No.1 Lactate-Producing and -Consuming Tissues
Under Basal Condition
Producers Consumers
Skin Liver
Erythrocytes Renal Cortex
Brain
Skeletal Muscles
Platelets
Leukocytes
Renal Medulla
Tissues of the Eye (Cornea, Lens, Retina)
WHERE IS LACTIC ACID FOUND ?
PATHOPHYSIOLOGY OF LACTIC ACIDOSIS
 Lactic acidosis occurs whenever there is Increased lactic
acid production and decreased utilization
 Types and causes of Lactic acidosis
1. Types A (hypoxic)
2. Types B (metabolic)
 Type A
 Due to hypoxia in tissues (most common)
 Hypoxia causes impaired oxidative phosphorylation and
decreased ATP synthesis
 To survive ,the cells switch to anaerobic glycolysis for
ATP synthesis
 This produces lactate as a final product
 The amount of oxygen required to recover oxygen
deficiency (Hypoxia) is called oxygen debt
 Type A is due to inadequate oxygen delivery in tissues
 Myocardial infarction
 Pulmonary embolism
 Tissue hypoperfusion( shock, cardiac arrest)
 Increased tissue demand (exercise, seizures, sepsis)
 Type B
 Due to disorders in carbohydrate metabolism
― Congenital lactic acidosis is due to deficiency of
pyruvate dehydrogenase enzyme
 Chronic hepatic disease a company by shock or bleeding
 Drug intoxication(ethanol, salicylate)
 Combination
Malignancy, Diabetes, Alcohol , HIV and Thiamine deficiency
 General malaise
 Loss of weight and loss of appetite
 Weakness and fatigue
 Nausea, and vomiting
 Tachypnoea
 Tachycardia
SIGNS AND SYMPTOMS
DIAGNOSIS
Diagnosis done by measuring blood lactate levels
Hyperlactemia: 2-5 mmols/L
Severe lactic acidosis: >5mmols/L
TREATMENT
 Treatment underlying disease
 Sodium bicarbonate
 hemodialysis
SODIUM BICARBONATE
 Sodium bicarbonate: May worsen oxygen delivery ,increase
lactate production especially in hypoxia induced glycolysis
 The surviving sepsis campaign recommended hold sodium
bicarbonate unless profound lactic acidosis and academia (
arterial pH less than 7.1 and serum bicarbonate 6meq/L or
less)
ALTERNATIVES TO BICARBONATE
THERAPY
 Tromethamine (tris-hydroxymethyl aminomethane also
called THAM, TRIS and TROMETAMOL
 Carbicarb
 Dichloroacetate (DCA)
None of these alternative agents have shown benefit in
pts with lactic acidosis
TRIS HYDROXYMETHYL AMINOMETHANE
(THAM)
 It is weak alkali and has a benefit over bicarbonate as it
produce less CO2
 Clinical trails do not prove THAM to be more effective
than bicarbonate
CARBICARB
 It is an equimolar combination of sodium carbonate and
sodium bicarbonate that produce less CO2 than sodium
bicarbonate alone
 Trials have not proven any reduction in mortality and
morbidity
DICHLOROACETATE
 It is an activator of pyruvate dehydrogenase
 It can lower conc: of lactic acid in pts by improving the
lactate utilization
 When used in large clinical trail it did not have any effect
on mortality
 DCA helpful in lactic acidosis in children with severe
malaria
HAEMODIALYSIS
 It is rarely indicated as a treatment for lactic acidosis
 It is used in drug toxicity ( Metformin induced lactic
acidosis)to speed up elimination of drug/toxin
 It is helpful when fluid overload and cardiac or renal
insufficiency is present
H
Lactic acidosis , diagnosis, causes, management
Lactic acidosis , diagnosis, causes, management
Lactic acidosis , diagnosis, causes, management

Lactic acidosis , diagnosis, causes, management

  • 1.
  • 2.
    INTRODUCTION  Lactic acidis the normal endpoint of the anaerobic breakdown of glucose in the tissues  Normal plasma lactate: 0.5 to 1.5 meq/L
  • 3.
    DEFINITION  Lactic acidosisis a pathological state diagnosed when the serum concentration of lactate or lactic acid is persistently 5mmol/l or greater  There is significant acidemia and serum pH< 7.35
  • 4.
    FORMATION OF LACTICACID  RBCs, brain and skin are major sources of lactic acid  During exercise skeletal muscles release significant amount of lactic acid  Liver and kidneys utilize lactic acid for biosynthesis of glucose  It is catalyzed by the enzyme lactate dehydrogenase
  • 5.
     The bodytissues produces 1500 mmoles of lactate each day  The lactate enters blood stream and metabolized meanly by liver (60% in Cori Cycle) and kidneys (30%) to glucose  All tissues can produce lactate under anaerobic conditions  Skeletal muscles produce high amounts of lactate during vigorous exercise  Oxygen may not reach the muscle fast enough to keep up with the workout LACTATE METABOLISM IN TISSUE
  • 8.
    PYRUVATE TO LACTATE The reduction of pyruvate by NADH+ catalyzed by to form lactate by lactate dehydrogenase on anaerobic glycolysis to generate ATP  The reaction takes place in the cells when the amount of oxygen is less, as in muscle during intense activity  Pyruvate lactate regenerates NAD+ which prevents glycolysis from cease to function  Lactate cannot be used to generate energy  Lactate must be removed from the muscles to prevent lactic acidosis
  • 9.
    Carried by the Bloodto the Liver to be converted into Glucose
  • 10.
    CORI CYCLE  Itis named after Carl Cori and Gerty Cori in 1929  It is also known as lactic acid cycle or glucose lactate or lactic acid fermentation  It involves the synthesis of glucose through gluconeogenesis from lactate synthesized in the skeletal muscle  It occurs when the muscles need energy or during hypoxia -Intense exercise -Sprinting
  • 11.
  • 13.
    Table No.1 Lactate-Producingand -Consuming Tissues Under Basal Condition Producers Consumers Skin Liver Erythrocytes Renal Cortex Brain Skeletal Muscles Platelets Leukocytes Renal Medulla Tissues of the Eye (Cornea, Lens, Retina)
  • 14.
    WHERE IS LACTICACID FOUND ?
  • 16.
    PATHOPHYSIOLOGY OF LACTICACIDOSIS  Lactic acidosis occurs whenever there is Increased lactic acid production and decreased utilization  Types and causes of Lactic acidosis 1. Types A (hypoxic) 2. Types B (metabolic)
  • 17.
     Type A Due to hypoxia in tissues (most common)  Hypoxia causes impaired oxidative phosphorylation and decreased ATP synthesis  To survive ,the cells switch to anaerobic glycolysis for ATP synthesis  This produces lactate as a final product  The amount of oxygen required to recover oxygen deficiency (Hypoxia) is called oxygen debt
  • 18.
     Type Ais due to inadequate oxygen delivery in tissues  Myocardial infarction  Pulmonary embolism  Tissue hypoperfusion( shock, cardiac arrest)  Increased tissue demand (exercise, seizures, sepsis)
  • 19.
     Type B Due to disorders in carbohydrate metabolism ― Congenital lactic acidosis is due to deficiency of pyruvate dehydrogenase enzyme  Chronic hepatic disease a company by shock or bleeding  Drug intoxication(ethanol, salicylate)  Combination Malignancy, Diabetes, Alcohol , HIV and Thiamine deficiency
  • 20.
     General malaise Loss of weight and loss of appetite  Weakness and fatigue  Nausea, and vomiting  Tachypnoea  Tachycardia SIGNS AND SYMPTOMS
  • 21.
    DIAGNOSIS Diagnosis done bymeasuring blood lactate levels Hyperlactemia: 2-5 mmols/L Severe lactic acidosis: >5mmols/L
  • 22.
    TREATMENT  Treatment underlyingdisease  Sodium bicarbonate  hemodialysis
  • 23.
    SODIUM BICARBONATE  Sodiumbicarbonate: May worsen oxygen delivery ,increase lactate production especially in hypoxia induced glycolysis  The surviving sepsis campaign recommended hold sodium bicarbonate unless profound lactic acidosis and academia ( arterial pH less than 7.1 and serum bicarbonate 6meq/L or less)
  • 24.
    ALTERNATIVES TO BICARBONATE THERAPY Tromethamine (tris-hydroxymethyl aminomethane also called THAM, TRIS and TROMETAMOL  Carbicarb  Dichloroacetate (DCA) None of these alternative agents have shown benefit in pts with lactic acidosis
  • 25.
    TRIS HYDROXYMETHYL AMINOMETHANE (THAM) It is weak alkali and has a benefit over bicarbonate as it produce less CO2  Clinical trails do not prove THAM to be more effective than bicarbonate
  • 26.
    CARBICARB  It isan equimolar combination of sodium carbonate and sodium bicarbonate that produce less CO2 than sodium bicarbonate alone  Trials have not proven any reduction in mortality and morbidity
  • 27.
    DICHLOROACETATE  It isan activator of pyruvate dehydrogenase  It can lower conc: of lactic acid in pts by improving the lactate utilization  When used in large clinical trail it did not have any effect on mortality  DCA helpful in lactic acidosis in children with severe malaria
  • 28.
    HAEMODIALYSIS  It israrely indicated as a treatment for lactic acidosis  It is used in drug toxicity ( Metformin induced lactic acidosis)to speed up elimination of drug/toxin  It is helpful when fluid overload and cardiac or renal insufficiency is present
  • 29.